BioSpace - Print News Article

Domain Therapeutics Fuels Pipeline With $2.9M 12/16/2008 8:46:38 AM Domain Therapeutics S.A. has added EUR2.1 million ($2.9 million) for the development of its pipeline targeting conditions including diabetes, Parkinson's disease and schizophrenia.

Domain Therapeutics Fuels Pipeline With $2.9M
12/16/2008 8:46:38 AM

Domain Therapeutics S.A. has added EUR2.1 million ($2.9 million) for the development of its pipeline targeting conditions including diabetes, Parkinson's disease and schizophrenia.